⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 11 December, 2014    By - Dr. Clemens
Anesthesia Management: Urine Drug Testing

UDT is Essential to Medical Care Primary care and family practice physicians are at the forefront of providing diverse patient populations with quality medical care that improves lives. Chronic pain is one of the leading reasons why patients visit their PCP or family doctor—who understands that uncontrolled chronic pain causes unnecessary suffering and can lead […]

Read More
Uncategorized Published - 10 December, 2014    By - Dr. Clemens
Anesthesia Management: Citing Past Successes, New Focus Is Entire Perioperative Period

Professor Francois Clergue, director of anesthesia of the University Hospitals of Geneva, challenged attendees of the European Society of Anaesthesiology (ESA) annual meeting here to extend their demonstrated success in improving anesthesia safety to address the entire perioperative period. The goal: Reduce postoperative mortality by 20%. Dr. Clergue, delivering the Sir Robert Macintosh Lecture, discussed […]

Read More
Uncategorized Published - 10 December, 2014    By - Dr. Clemens
Anesthesia Management: Perioperative Fluids: An Evidence-Based Review

This was written by Elizabeth A. M. Frost, MD Professor of Anesthesia Icahn School of Medicine at Mount Sinai New York, New York Many questions have arisen and much controversy has emerged regarding how much fluid should be given perioperatively, which fluids should be given, when they should be given, and whether outcomes can be […]

Read More
Uncategorized Published - 10 December, 2014    By - Dr. Clemens
Anesthesia Management: Long-Term Outcomes of Single Corticosteroid Injections for Trigger Finger

This is for our readers who practice pain management. Authors: Wojahn RD et al., J Bone Joint Surg Am 2014 Nov 19; 96:1849 Almost half of patients required no additional injections. The estimated lifetime risk for trigger finger is about 3% in the general population and as high as 10% in diabetic patients. Treatment options […]

Read More
Uncategorized Published - 10 December, 2014    By - Dr. Clemens
Anesthesia Management: Promising New Drug for Migraine Prevention

Excitement is mounting about a new class of drugs for migraine prevention. In one of the most recent developments, a new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Results also showed that adverse events associated with the drug were […]

Read More